Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial

Elizabeth Anne Oliphant, Christopher Jd McKinlay, David McNamara, Alana Cavadino, Jane M Alsweiler, Elizabeth Anne Oliphant, Christopher Jd McKinlay, David McNamara, Alana Cavadino, Jane M Alsweiler

Abstract

Objective: To establish the most effective and best tolerated dose of caffeine citrate for the prevention of intermittent hypoxaemia (IH) in late preterm infants.

Design: Phase IIB, double-blind, five-arm, parallel, randomised controlled trial.

Setting: Neonatal units and postnatal wards of two tertiary maternity hospitals in New Zealand.

Participants: Late preterm infants born at 34+0-36+6 weeks' gestation, recruited within 72 hours of birth.

Intervention: Infants were randomly assigned to receive a loading dose (10, 20, 30 or 40 mg/kg) followed by 5, 10, 15 or 20 mg/kg/day equivolume enteral caffeine citrate or placebo daily until term corrected age.

Primary outcome: IH (events/hour with oxygen saturation concentration ≥10% below baseline for ≤2 min), 2 weeks postrandomisation.

Results: 132 infants with mean (SD) birth weight 2561 (481) g and gestational age 35.7 (0.8) weeks were randomised (24-28 per group). Caffeine reduced the rate of IH at 2 weeks postrandomisation (geometric mean (GM): 4.6, 4.6, 2.0, 3.8 and 1.7 events/hour for placebo, 5, 10, 15 and 20 mg/kg/day, respectively), with differences statistically significant for 10 mg/kg/day (GM ratio (95% CI] 0.39 (0.20 to 0.76]; p=0.006) and 20 mg/kg/day (GM ratio (95% CI] 0.33 (0.17 to 0.68]; p=0.003) compared with placebo. The 20 mg/kg/day dose increased mean (SD) pulse oximetry oxygen saturation (SpO2) (97.2 (1.0) vs placebo 96.0 (0.8); p<0.001), and reduced median (IQR) percentage of time SpO2 <90% (0.5 (0.2-0.8) vs 1.1 (0.6-2.4); p<0.001) at 2 weeks, without significant adverse effects on growth velocity or sleeping.

Conclusion: Caffeine reduces IH in late preterm infants at 2 weeks of age, with 20 mg/kg/day being the most effective dose.

Trial registration number: ACTRN12618001745235.

Keywords: neonatology; respiratory medicine; therapeutics.

Conflict of interest statement

Competing interests: JMA chairs the policy subcommittee of the Perinatal Society of Australia and New Zealand. This is a service role in a professional society for which no payment is received. The authors have no other competing interests to declare.

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Flow diagram of trial participants.

References

    1. United States Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) . Natality public-use data 2016-2020, on CDC wonder online database, 2021. Available: [Accessed 06 Dec 2021].
    1. Ministry of Health . Report on maternity web tool (NZ births 2009-2019), 2021. Available: [Accessed 06 Dec 2021].
    1. Engle WA, Tomashek KM, Wallman C, et al. . "Late-preterm" infants: a population at risk. Pediatrics 2007;120:1390–401. 10.1542/peds.2007-2952
    1. McIntire DD, Leveno KJ. Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol 2008;111:35–41. 10.1097/01.AOG.0000297311.33046.73
    1. Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008;359:262–73. 10.1056/NEJMoa0706475
    1. Odd DE, Lingam R, Emond A, et al. . Movement outcomes of infants born moderate and late preterm. Acta Paediatr 2013;102:876–82. 10.1111/apa.12320
    1. Darlow BA, Horwood LJ, Wynn-Williams MB, et al. . Admissions of all gestations to a regional neonatal unit versus controls: 2-year outcome. J Paediatr Child Health 2009;45:187–93. 10.1111/j.1440-1754.2008.01457.x
    1. Woythaler MA, McCormick MC, Smith VC. Late preterm infants have worse 24-month neurodevelopmental outcomes than term infants. Pediatrics 2011;127:e622–9. 10.1542/peds.2009-3598
    1. Cheong JL, Doyle LW, Burnett AC, et al. . Association between moderate and late preterm birth and neurodevelopment and social-emotional development at age 2 years. JAMA Pediatr 2017;171:e164805. 10.1001/jamapediatrics.2016.4805
    1. Talge NM, Holzman C, Wang J, et al. . Late-preterm birth and its association with cognitive and socioemotional outcomes at 6 years of age. Pediatrics 2010;126:1124–31. 10.1542/peds.2010-1536
    1. Quigley MA, Poulsen G, Boyle E, et al. . Early term and late preterm birth are associated with poorer school performance at age 5 years: a cohort study. Arch Dis Child Fetal Neonatal Ed 2012;97:F167–73. 10.1136/archdischild-2011-300888
    1. Heinonen K, Eriksson JG, Lahti J, et al. . Late preterm birth and neurocognitive performance in late adulthood: a birth cohort study. Pediatrics 2015;135:e818–25. 10.1542/peds.2014-3556
    1. Berry MJ, Foster T, Rowe K, et al. . Gestational age, health, and educational outcomes in adolescents. Pediatrics 2018;142. 10.1542/peds.2018-1016
    1. Williams LZJ, McNamara D, Alsweiler JM. Intermittent hypoxemia in infants born late preterm: a prospective cohort observational study. J Pediatr 2019;204:89–95. 10.1016/j.jpeds.2018.08.048
    1. Askie LM, Darlow BA, Finer N, et al. . Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective meta-analysis collaboration. JAMA 2018;319:2190–201. 10.1001/jama.2018.5725
    1. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo WA, Finer NN, et al. . Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010;362:1959–69. 10.1056/NEJMoa0911781
    1. Stenson B, Brocklehurst P, Tarnow-Mordi W, et al. . Increased 36-week survival with high oxygen saturation target in extremely preterm infants. N Engl J Med 2011;364:1680–2. 10.1056/NEJMc1101319
    1. Poets CF, Roberts RS, Schmidt B, et al. . Association between intermittent hypoxemia or bradycardia and late death or disability in extremely preterm infants. J Am Med Assoc 2015;314:595–603. 10.1001/jama.2015.8841
    1. Schmidt B, Roberts RS, Davis P, et al. . Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007;357:1893–902. 10.1056/NEJMoa073679
    1. Schmidt B, Roberts RS, Davis P, et al. . Caffeine therapy for apnea of prematurity. N Engl J Med 2006;354:2112–21. 10.1056/NEJMoa054065
    1. McNamara DG, Nixon GM, Anderson BJ. Methylxanthines for the treatment of apnea associated with bronchiolitis and anesthesia. Paediatr Anaesth 2004;14:541–50. 10.1111/j.1460-9592.2004.01351.x
    1. Le Guennec JC, Billon B, Paré C. Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding. Pediatrics 1985;76:834–40. 10.1542/peds.76.5.834
    1. Falcão AC, Fernández de Gatta MM, Delgado Iribarnegaray MF, et al. . Population pharmacokinetics of caffeine in premature neonates. Eur J Clin Pharmacol 1997;52:211–7. 10.1007/s002280050276
    1. Rhein LM, Dobson NR, Darnall RA, et al. . Effects of caffeine on intermittent hypoxia in infants born prematurely: a randomized clinical trial. JAMA Pediatr 2014;168:250–7. 10.1001/jamapediatrics.2013.4371
    1. Steer P, Flenady V, Shearman A, et al. . High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2004;89:F499–503. 10.1136/adc.2002.023432
    1. Oliphant EA, McKinlay CJD, McNamara DG, et al. . (Rad 8)Caffeine prophylaxis to improve intermittent hypoxaemia in infants born late preterm: a randomised controlled dosage trial (Latte Dosage Trial). BMJ Open 2020;10:38271. 10.1136/bmjopen-2020-038271
    1. Wellington G, Elder D, Campbell A. 24-Hour oxygen saturation recordings in preterm infants: editing artefact. Acta Paediatr 2018;107:1362–9. 10.1111/apa.14293
    1. Bühler E, Lachenmeier DW, Schlegel K. Development of a tool to assess the caffeine intake among teenagers and young adults. Science & Research 2013;17. 10.4455/eu.2014.011
    1. Kleinman L, Rothman M, Strauss R, et al. . The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument. Clin Gastroenterol Hepatol 2006;4:588–96. 10.1016/j.cgh.2006.02.016
    1. Bosquet Enlow M, White MT, Hails K, et al. . The infant behavior questionnaire-revised: factor structure in a culturally and sociodemographically diverse sample in the United States. Infant Behav Dev 2016;43:24–35. 10.1016/j.infbeh.2016.04.001
    1. Gartstein MA, Rothbart MK. Studying infant temperament via the revised infant behavior questionnaire. Infant Behav Dev 2003;26:64–86. 10.1016/S0163-6383(02)00169-8
    1. Oliphant EA, Purohit TJ, Alsweiler JM, et al. . Validation and application of a simple and rapid stability-indicating liquid chromatographic assay for the quantification of caffeine from human saliva. J Liq Chromatogr Relat Technol 2022;137:1–8. 10.1080/10826076.2022.2095402
    1. Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997;53:983–97. 10.2307/2533558
    1. Chen J, Jin L, Chen X. Efficacy and safety of different maintenance doses of caffeine citrate for treatment of apnea in premature infants: a systematic review and meta-analysis. Biomed Res Int 2018;2018:1–11. 10.1155/2018/9061234
    1. Mohammed S, Nour I, Shabaan AE, et al. . High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial. Eur J Pediatr 2015;174:949–56. 10.1007/s00431-015-2494-8
    1. Rhein L, Simoneau T, Davis J, et al. . Reference values of nocturnal oxygenation for use in outpatient oxygen weaning protocols in premature infants. Pediatr Pulmonol 2012;47:453–9. 10.1002/ppul.21562
    1. Bass JL, Corwin M, Gozal D, et al. . The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence. Pediatrics 2004;114:805–16. 10.1542/peds.2004-0227
    1. Almendros I, Wang Y, Gozal D. The polymorphic and contradictory aspects of intermittent hypoxia. Am J Physiol Lung Cell Mol Physiol 2014;307:L129–40. 10.1152/ajplung.00089.2014
    1. Kreutzer K, Bassler D. Caffeine for apnea of prematurity: a neonatal success story. Neonatology 2014;105:332–6. 10.1159/000360647
    1. Dobson NR, Rhein LM, Darnall RA, et al. . Caffeine decreases intermittent hypoxia in preterm infants nearing term-equivalent age. J Perinatol 2017;37:1135–40. 10.1038/jp.2017.82
    1. Preston C. Stockley’s Drug Interactions. Available: [Accessed 03 Jun 2022].
    1. Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013;13:59. 10.1186/1471-2431-13-59
    1. Patel AL, Engstrom JL, Meier PP, et al. . Calculating postnatal growth velocity in very low birth weight (VLBW) premature infants. J Perinatol 2009;29:618–22. 10.1038/jp.2009.55

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera